Antimullerian hormone versus the clomiphene citrate challenge test for evaluation of ovarian reserve prior to in vitro fertilization

2013 ◽  
Vol 100 (3) ◽  
pp. S493
Author(s):  
A.C. Eblen ◽  
M. Freeman ◽  
G. Hill ◽  
C. Whitworth ◽  
G. Weitzman
2021 ◽  
Vol 1 (3) ◽  
Author(s):  
José Manuel Lozano Sánchez

Objective: To study the importance of immunological screening (CH50, C3, C4) to determine the correlation between the ovarian reserve and complement pathway. Design: A cross-sectional multivariate study. Setting: Single tertiary referral center. Patients: 40 Women with infertility diagnosis who underwent In Vitro Fertilization (IVF). Intervention(s): Basal blood samples collected to measure complement pathway and antimüllerian hormone. Main Outcome Measure(s): To correlate complement pathways (CH50 levels) with AMH. Results: The complement system and ovarian reserve were studied in 40 women aged from 28-48 years (mean=37.87 years), finding the values of CH50 65-268 CAE (mean=153.2 CAE), C3 13.9- 183mg/dl (mean=128.52mg/dl), C4 11.5-106mg/dl (mean=29.86mg/dl), AMH 0.10-3.9ng/dl (mean=1.32ng/dl). A multivariate analysis comparison was also conducted yielding significant results: negative correlation between AMH and age (Spearman correlation -0.6; P=0.001), as well as between AMH and CH50 (Spearman correlation -0.4; P=0.0129). Conclusion: High CH50 levels are correlated with an AMH decrease and it could be accordingly associated with age-related chronic inflammation. Capsule: High levels of CH50 are correlated with a decrease in AMH levels and could also be considered as a marker of poor response in IVF cycles.


2009 ◽  
Vol 70 (4) ◽  
pp. 230-234 ◽  
Author(s):  
F. Guerif ◽  
M. Lemseffer ◽  
M.-L. Couet ◽  
O. Gervereau ◽  
V. Ract ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document